Coeptis Therapeutics Holdings, Inc. (COEP)
14.30
-0.40
(-2.72%)
USD |
NASDAQ |
Jan 09, 16:00
14.36
+0.06
(+0.42%)
Pre-Market: 20:00
Coeptis Therapeutics Holdings Total Liabilities (Quarterly): 3.265M for Sept. 30, 2025
Total Liabilities (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| CEL-SCI Corp. | 12.20M |
| AIM ImmunoTech, Inc. | 11.57M |
| IGC Pharma, Inc. | 1.651M |
| NovaBay Pharmaceuticals, Inc. | 1.853M |
| Protalix Biotherapeutics, Inc. | 29.36M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 16.28M |
| Shareholders Equity (Quarterly) | 12.47M |
| Debt to Equity Ratio | 0.0225 |
| Current Ratio | 2.214 |
| Net Debt Paydown Yield | 0.33% |